AVIGI Therapeutics Welcomes Dr. Alessandro Noseda as Medical Advisor AVIGI Therapeutics, a pioneering biotechnology company leveraging biomimetic rational drug design and advanced chemistry, is pleased to announce the appointment of Dr. Alessandro Noseda as its Medical...
FROM BENCH TO BREAKTHROUGH: AVIGI THERAPEUTICS SECURES €350K BOOST LEIDEN, APRIL 4, 2025 — Well, that just happened! After countless late nights in the lab, enough caffeine to fill the Rhine, and more pipette tips than we care to count, AVIGI Therapeutics has officia...
AVIGI will be attending BIO Europe Spring 2025 in Milan! When? 17 - 19 March 2025 Where? Bio Europe Spring: Italy 🇮🇹 - Milan Why? As we advance our innovative therapeutic programs in oncology and inflammatory diseases, we're eager to engage with industry le...